NCT Number: NCT02125370
Experiences of Pregnant Women Who Use NRT in Pregnancy as Part of a Quit Attempt
This study is largely a qualitative study with a small survey component. The aim of the survey would be to gain a quantitative perspective of how women use NRT after this has been prescribed by stop smoking services (SSS). The aim of the qualitative study would be to enhance knowledge of pregnant smoker's views and attitudes about their experiences of using NRT and in particular to understand why pregnant women who start using NRT often discontinue this early or do not use the medication as it is prescribed. This information is important for a number of reasons; firstly it will help health professionals and researchers gain an in depth understanding about how women experience using NRT, which may be used to help devise strategies for encouraging better adherence and which could be used in future clinical trials to gain a clearer understanding as to whether or not NRT is effective in pregnancy.
Looking for future studies?
Notify MeKey information
Conditions
Age range
16 year and older
Sex eligibility
Female
Study type
Observational
Primary location
University of Nottingham, Nottingham, Nottinghamshire, United Kingdom
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Quantitative survey;
- Women who are pregnant
- Aged 16 or over (no upper age limit)
- Who have been prescribed NRT (patches/dual therapy) to aid a quit attempt.
Qualitative interview study will include the above plus;
- Women will have used NRT for over 24 hours
- Either not be using NRT as prescribed (as deciphered by the survey questions) or have currently quit NRT (and have either stopped smoking or continue to smoke)
Exclusion criteria
- Survey and qualitative interviews
- Women who cannot understand the study procedure sufficiently in order to provide consent e.g. due to cognitive difficulties
- Women who are unable to read or understand the consent procedure and study procedures in English.
Treatment and study plan
Primary outcomes
-
number of women that use NRT after being prescribed
Time frame: within 4 weeks of taking part in the study
All women will be asked whether they have used NRT after being given a prescription, this measurement will be obtained within 4 weeks of the participant consenting to take part in the study.
Secondary outcomes
-
Number of women who adhere to NRT
Time frame: 4 weeks
Sponsors and collaborators
Lead sponsor
University of Nottingham
Other
Registry information
Important dates
- Study start
- 2014
- Primary completion
- 2014
- Study completion
- 2014
- First posted
- Apr 29, 2014
- Registry last updated
- Dec 4, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Multiple Micronutrient Versus Iron-Folic Acid Supplementation in Pregnant Women in Indonesia
NCT07725549
Birth Weight, Body Weight
Purwodadi Grobogan, Central Java, Indonesia
View Trial DetailsEvaluation of Conditional Cash Transfers to Increase Retention in PMTCT Services in Akwa Ibom State, Nigeria
NCT02447159
Behavior, Blood-Borne Infections
Eket, Akwa Ibom State, Nigeria
View Trial DetailsChildbirth Education Classes, Spousal Support, Birth Memory, Choice of the Birth Method, and Birth Satisfaction
NCT07072507
Birth, Birth Memory
Bursa, Turkey (Türkiye)
View Trial DetailsClinical Study of STI Screening to Prevent Adverse Birth and New-born Outcomes (Philani Ndiphile)
NCT04446611
Acquired Immunodeficiency Syndrome, Antenatal Care
East London, Eastern Cape, South Africa
View Trial Details